CERO - Historical Earnings Price Analysis
Source: KlickAnalytics
2025-11-17 17:37:00 ET
CERo Therapeutics Holdings, Inc. (CERO) - Following Earnings Price Analysis was done using last 12 quarters historical earnings.
Opening Gap Moves
Actual Earning Moves
Full story available on KlickAnalytics.com
CERo Therapeutics Holdings Inc.
NASDAQ: CERO
CERO Trading
-94.36% G/L:
$0.242 Last:
15,954,575 Volume:
$0.3383 Open:
CERO Latest News
February 17, 2026 08:00:00 am
CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors
February 04, 2026 09:05:00 am
CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient
January 07, 2026 09:09:00 am
CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion-Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML
December 17, 2025 08:00:00 am
CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)
CERO Stock Data
$927,071
19,556,591
56.15%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
